BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8391244)

  • 1. Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data.
    Kuo TH; Kubota T; Watanabe M; Furukawa T; Kase S; Tanino H; Saikawa Y; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1993; 13(3):627-30. PubMed ID: 8391244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthotopic reconstitution of human small-cell lung carcinoma after intravenous transplantation in SCID mice.
    Kuo TH; Kubota T; Watanabe M; Furukawa T; Kase S; Tanino H; Nishibori H; Saikawa Y; Teramoto T; Ihsibiki K
    Anticancer Res; 1992; 12(5):1407-10. PubMed ID: 1332577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
    Geiger T; Müller M; Monia BP; Fabbro D
    Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
    Hoffman RM
    Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.
    Han Z; Wyche JH; Sands H; Pantazis P
    Anticancer Res; 2001; 21(3B):1823-7. PubMed ID: 11497265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
    Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation.
    Kubota T
    J Cell Biochem; 1994 Sep; 56(1):4-8. PubMed ID: 7806591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new patient-like metastatic model of human small-cell lung cancer constructed orthotopically with intact tissue via thoracotomy in nude mice.
    Wang X; Fu X; Kubota T; Hoffman RM
    Anticancer Res; 1992; 12(5):1403-6. PubMed ID: 1332576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of patient-like SCID mouse model by orthotopically implanting primary cultured cells from surgically-resected lung cancer tissues.
    Fujino H; Kondo K; Miyoshi T; Ishikura H; Takahashi Y; Sawada N; Hirose Y; Takizawa H; Nagao T; Sakiyama S; Monden Y
    Oncol Rep; 2003; 10(6):1709-15. PubMed ID: 14534683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCID mouse lymphogenous metastatic model of human lung cancer constructed using orthotopic inoculation of cancer cells.
    Miyoshi T; Kondo K; Ishikura H; Kinoshita H; Matsumori Y; Monden Y
    Anticancer Res; 2000; 20(1A):161-3. PubMed ID: 10769649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of a new topoisomerase I and II inhibitor TAS-103, against both P-glycoprotein-expressing and -nonexpressing drug-resistant human small-cell lung cancer.
    Parajuli P; Yano S; Nishioka Y; Nokihara H; Hanibuchi M; Nishimura N; Utsugi T; Sone S
    Oncol Res; 1999; 11(5):219-24. PubMed ID: 10608616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.
    Onn A; Isobe T; Itasaka S; Wu W; O'Reilly MS; Ki Hong W; Fidler IJ; Herbst RS
    Clin Cancer Res; 2003 Nov; 9(15):5532-9. PubMed ID: 14654533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
    Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthotopic SCID mouse model with two newly established human lung squamous carcinoma cell lines.
    Mirzaie M; Gunawan B; Meyer T; Herse B; Füzesi L; Ruschewski W
    Anticancer Res; 2002; 22(1A):145-9. PubMed ID: 12017278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
    Budak-Alpdogan T; Chen B; Warrier A; Medina DJ; Moore D; Bertino JR
    Clin Cancer Res; 2009 Feb; 15(4):1232-40. PubMed ID: 19174488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthotopically implanted SCID mouse model of human lung cancer suitable for investigating metastatic potential and anticancer drug effects.
    Kondo K; Fujino H; Miyoshi T; Ishikura H; Sakiyama S; Monden Y
    Oncol Rep; 2004 Nov; 12(5):991-9. PubMed ID: 15492783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
    Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
    Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.